ColoCare Study - Colorectal Cancer Cohort
ColoCare is an international prospective cohort study of stage I-IV colorectal cancer patients (ICD-10 C18-C20).
| Condition(s) | Colorectal Cancer |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | ColoCare is an international prospective cohort study of stage I-IV colorectal cancer patients (ICD-10 C18-C20). |
| Who can participate | Inclusion Criteria: 1. Age 18-89 years; for patients recruited after 09/01/2021 the age range is 18-69 years. Recruitment of patients 70 years and older was maintained for specific sub-studies and re-initiated for specific R01 grant funding in \~06/2024 2. Men and women 3. Newly-diagnosed colon or rectal cancer (stages I-IV); CRC in treatment (FHCRC and HCI) 4. English (FHCRC, Moffitt, HCI, Cedars-Sinai, WashU St. Louis) or German (University Hospital Heidelberg)-speaking; 5. mentally/physically able to consent and participate. Exclusion Criteria: * if one of the above in not fulfilled * insufficient language or consent capacity |
| Ages | 18 Years to 89 Years |
| Sex | All |
| Lead sponsor | University of Utah |
| Locations | Los Angeles, California, United States; Tampa, Florida, United States; St Louis, Missouri, United States; Knoxville, Tennessee, United States; Salt Lake City, Utah, United States; Seattle, Washington, United States (+1 more sites) |
| Start date | 2007-03 |
| NCT ID | NCT02328677 |
| Official listing | https://clinicaltrials.gov/study/NCT02328677 |